ALMSCO to showcase latest products at Pittcon 2013.
Preterm birth risk diagnostic test to be given boost by partnership between Agilent Technologies and Sera PrognosticsPreterm birth risk diagnostic test to be given boost by partnership between Agilent Technologies and Sera Prognostics
Agilent has entered a partnership with the women’s health company to develop proteomic assays for fetal and maternal health.
Trovagene have recently announced that their urine-based HPV Carrier and oncogene mutation tests are expected to achieve analytical and clinical validation in March 2013.
New Prelude SPLC system makes LC-MS/MS analysis more user friendly.
Global team of scientists has developed a representation of human metabolism applicable to computational modeling.
Research partnership hopes to use novel proteomic MS techniques to provide a deeper understanding of disease mechanisms.
Bayer HealthCare calls forth pharmaceutical companies, small and medium enterprises and academics.
Stuart Meredith is announced as PharmaTimes magazine’s ‘Clinical Research Associate of the Year’.
Selventa announce development focus on a new class of diagnostic test for autoimmune disease and cancer
‘Multi-omic’ biomarker diagnostics will look to improve patient therapy selection.
Kinetic isotope effects do not bias doping control analysis, say researchers at the Doping Control Laboratory at the Olympic Athletic Center of Athens.